| ASSET | QUARTER | % RETURN |
|---|---|---|
Quantum Computing (QUBT) | Q3 2018 | 379.17% |
CleanSpark (CLSK) | Q3 2018 | 195% |
Liquidia Technologies (LQDA) | Q3 2018 | 120.32% |
Viking Therapeutics (VKTX) | Q3 2018 | 83.18% |
Scholar Rock (SRRK) | Q3 2018 | 64.12% |
Workiva (WK) | Q3 2018 | 62.89% |
CarGurus (CARG) | Q3 2018 | 60.81% |
Glaukos (GKOS) | Q3 2018 | 59.89% |
Paycom Software (PAYC) | Q3 2018 | 58.76% |
Protagonist Therapeutics (PTGX) | Q3 2018 | 53.81% |
Cleveland-Cliffs (CLF) | Q3 2018 | 52.53% |
Molina Healthcare (MOH) | Q3 2018 | 52.19% |
Match (MTCH) | Q3 2018 | 51.84% |
Crinetics Pharmaceuticals (CRNX) | Q3 2018 | 48.83% |
Xenon Pharmaceuticals (XENE) | Q3 2018 | 46.67% |
Kiniksa Pharmaceuticals (KNSA) | Q3 2018 | 46.64% |
Mercury Systems (MRCY) | Q3 2018 | 46.04% |
Denali Therapeutics (DNLI) | Q3 2018 | 44.74% |
United Parks & Resorts (PRKS) | Q3 2018 | 44.31% |
IAC (IAC) | Q3 2018 | 43.47% |
PTC Therapeutics (PTCT) | Q3 2018 | 43.34% |
Alarm (ALRM) | Q3 2018 | 42.86% |
Energy Fuels (UUUU) | Q3 2018 | 41.38% |
NMI (NMIH) | Q3 2018 | 40.25% |
Arrowhead Pharmaceuticals (ARWR) | Q3 2018 | 39.82% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
